Magenta Therapeutics is down a bit on the day, funds flowing out kept the price down -1.33% since yesterday.
The Biotechnology company isn't at an immediate support or resistance level that might be predictive. Magenta Therapeutics hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. MGTA might find some support at the 0.9528 level, buyers might push the price back up from here. But it's not very clear what will happen.
Analysts are currently taking a negative view on their future outlook for Magenta Therapeutics. It's not really bad but definitely not good. The current Analysts Sentiment Score is -88.31. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. On 2023-02-28 HC Wainwright initiated their coverage and rated as Neutral. Cowen reiterated a rating of Outperform on 2023-01-26. On 2023-01-26 there was a downgrade announced by Wedbush from Outperform to Neutral. On 2023-01-26 there was a downgrade announced by BTIG Research from Buy to Neutral. The Goldman Sachs Group downgraded from Buy to Neutral on 2022-08-24 and provided a price target of $2.00. Mizuho announced a lowering of their price target to $8.00 from $17.00 on 2022-04-18. B. Riley announced a lowering of their price target to $6.00 from $13.00 on 2022-01-24. JPMorgan Chase & Co. released a downgrade on 2021-08-03 from Overweight to Neutral and dropped their 1 year price target to $7.00 which is down from $16.00. Cantor Fitzgerald announced that they are initiating coverage with a rating of Overweight on 2021-06-29 and they set their price target at $20.00.
Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
---|---|---|---|---|---|
MGTA | -88.31 | 0.45 | -173.91 | 0.45 | -3.6 |
Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
---|---|---|
MGTA | 13.73 | -3.63 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
---|---|---|---|---|---|
MGTA | 15.35 | %12.8 | 4.1 | 100 | 4930000 |
Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology | 367 | 1.85 | -0.88 | -10.56 | 1.85 | -7.04 | -22.15 | 31.57 | -13.77 | -17.27 | -13.81 | -41814.93 | -3164.24 | 0.95 | 21.19 | 6.54 | 48.84 |
Healthcare | 617 | 2.00 | -0.17 | -8.49 | 2.07 | -6.13 | -23.93 | 31.85 | -11.33 | -14.45 | -14.07 | -36805.91 | -4054.41 | 1.05 | 22.33 | 5.93 | 36.37 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
Ticker | Social Sentiment(1-10) |
---|---|
MGTA | 6.00 |
Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
VKTX | Viking Therapeutics, Inc | 0.91 | -19.35 | -12.17 | -14.65 | 15.95 | 205.54 | 188.62 | 32 | 93.72 | 128.46 | 106.04 | -2064.43 | -23764.37 | 0 | 0 | 1.84923 |
ARWR | Arrowhead Research Corpor | 0.83 | -1.84 | -2.84 | -25.11 | -35.62 | -27.30 | -45.81 | 4 | -11.76 | -20.65 | -18.17 | -34746.31 | 0.00 | 0 | 150 | 4.85006 |
BNGO | Bionano Genomics, Inc. Co | 0.82 | 5.56 | -5.00 | -19.72 | -27.85 | -46.48 | -50.00 | 31 | -53.77 | -37.25 | -29.33 | -29199.71 | 0.00 | 0 | 0 | 13.4431 |
MDGL | Madrigal Pharmaceuticals, | 0.81 | -4.02 | 2.86 | -15.83 | -14.44 | 277.10 | 159.25 | 15 | 39.54 | 49.63 | 56.05 | -2960.99 | -21355.70 | 0 | 0 | 13.2455 |
GTHX | G1 Therapeutics, Inc. Com | 0.8 | 7.14 | -3.67 | -16.45 | -45.03 | -77.89 | -61.96 | 30 | -70.01 | -64.39 | -39.25 | -25686.68 | 0.00 | 0 | 0 | 7.14626 |
CDLX | Cardlytics, Inc. Common S | 0.74 | 17.11 | 2.95 | -43.44 | -26.45 | -69.70 | -93.83 | 4 | -69.25 | -60.15 | -46.55 | -102485.33 | 187.25 | 0 | 150 | 8.41537 |
KRTX | Karuna Therapeutics, Inc. | 0.73 | -11.60 | -13.76 | -15.14 | -20.30 | -33.30 | 38.99 | 30 | 14.75 | 10.26 | 5.85 | -9676.86 | -11045.08 | 0 | 100 | 5.17169 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.